Results for tag: "Multi Infarct Dementia Drug"

Multi Infarct Dementia (MID) is a type of dementia caused by multiple small strokes in the brain. It is a form of vascular dementia, which is the second most common type of dementia after Alzheimer's disease. MID is characterized by a gradual decline in cognitive abilities, including memory, language, and problem-solving. Treatment for MID typically involves medications to reduce the risk of further strokes, as well as lifestyle changes to reduce the risk of stroke. Central Nervous System (CNS) drugs are used to treat a variety of neurological conditions, including MID. These drugs can help reduce the risk of stroke, improve cognitive function, and slow the progression of the disease. Common CNS drugs used to treat MID include anticoagulants, antiplatelet agents, and statins. In addition, some medications may be used to treat the symptoms of MID, such as depression, anxiety, and agitation. Companies in the Multi Infarct Dementia Drug market include Pfizer, Novartis, Merck, and GlaxoSmithKline. These companies produce a variety of medications to treat MID, including anticoagulants, antiplatelet agents, and statins. Show Less Read more